RET and hereditary pheochromocytoma-paraganglioma: Activating mutations in RET have been documented in human PTC and MTC, multiple endocrine neoplasia 2 syndromes, pheochromocytoma, and paragangliomas that are known to drive tumor cell growth [28][29].